ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ: AVNR) today announced that it will release complete financial results for the three months ended December 31, 2007 before market open on Thursday, February 7, 2008. Keith Katkin, President and Chief Executive Officer; Randall Kaye, M.D., Senior Vice President and Chief Medical Officer; and Christine Ocampo, Corporate Controller, will host an investment community conference call that same day at 8:00 a.m. Pacific time / 11:00 a.m. Eastern time to discuss those results and answer questions.
